Specific signaling effectors (AKT, CBL, JNK, PLC-γ and STAT1) were significantly activated in the PBMC of ERA patients compared with healthy individuals. The gene discussed is AKT1; the disease is enthesitis-related juvenile idiopathic arthritis.